Identification of degradation products of terbutol in environmental water from golf courses

1995 ◽  
Vol 43 (6) ◽  
pp. 1712-1717 ◽  
Author(s):  
Toshinari Suzuki ◽  
Kumiko Yaguchi ◽  
Kazuo Ohnishi ◽  
Tetsuya Suga
Keyword(s):  
Degradation Products ◽  
Environmental Water ◽  
Golf Courses

scholarly journals Determination of Dichlorvos, Trichlorfon and Their Metabolites and Degradation Products in Environmental Water, Drinks and Human Urine.

Eisei kagaku ◽  
1993 ◽  
Vol 39 (5) ◽  
pp. 459-468 ◽  
Author(s):  
MUNEHIRO KATAGI ◽  
HITOSHI TSUCHIHASHI ◽  
SAYORI HANADA ◽  
HIROE JINMORI ◽  
KAZUO OTSUKI
Keyword(s):  
Human Urine ◽  
Degradation Products ◽  
Environmental Water

scholarly journals Degradation of 1H-benzotriazole using vacuum ultraviolet: a prospective treatment method for micro-pollutants

2019 ◽  
Vol 80 (4) ◽  
pp. 773-783 ◽  
Author(s):  
Jinshao Ye ◽  
Han Hu ◽  
Ya Chen ◽  
Yujia Chen ◽  
Huase Ou
Keyword(s):  
Vacuum Ultraviolet ◽  
Degradation Products ◽  
Water Solution ◽  
Pure Water ◽  
Radical Reaction ◽  
Treatment Method ◽  
Environmental Water ◽  
Open Loop ◽  
Radical Trapping ◽  
Uv C

Abstract Benzotriazoles (BTs) attract increasing concerns because of abundant presence in environmental water bodies. In this study, degradation of 1H-benzotriazole (1H-BT) was performed by a customized vacuum ultraviolet (VUV) device emitting 185 + 254 nm (VUV/UV-C) irradiation. Degradation of 1H-BT presented an apparent rate constant reached 8.17 × 10−4 s−1. Degradation mechanisms included 185 + 254 nm photodegradation and radical reaction. The later one may be the predominant one, which presented a k·OH-1H-BT at (7.3 ± 0.8) × 109 M−1 s−1. Effects of anions revealed that VUV interception and radical trapping were the dominant restraining factors. Degradation of 1H-BT can be attributed to VUV induced radical-based oxidation. Radical-induced addition, substitution and fracture generated abundant hydroxylated and open-loop products during 10–45 min. Identification using reactive oxygen species and apoptosis in Escherichia coli was conducted. Variations of these two indicators revealed that the incomplete degradation products presented higher toxicities than 1H-BT, and a further mineralization reduced their toxicities. In the pure water solution with little impurities, VUV can induce efficient degradation of 1H-BT, suggesting its potential for eliminating and detoxifying MPs.

Hollow fiber-liquid phase microextraction for trace enrichment of the residues of atrazine and its major degradation products from environmental water and human urine samples

2015 ◽  
Vol 7 (23) ◽  
pp. 9940-9948 ◽  
Author(s):  
Negussie Megersa
Keyword(s):  
Liquid Phase ◽  
Hollow Fiber ◽  
Human Urine ◽  
Degradation Products ◽  
Environmental Water ◽  
Urine Samples ◽  
Environmental Waters ◽  
Liquid Phase Microextraction ◽  
Trace Enrichment ◽  
Human Urine Samples

Miniaturized HF-LPME for trace enrichment of atrazine and its degradation products from environmental waters and human urine samples.

Collagen degradation products modulate matrix metalloproteinase expression in cultured articular chondrocytes

2005 ◽  
Vol 24 (1) ◽  
pp. 63-70 ◽  
Author(s):  
M. Fichter ◽  
U. Körner ◽  
J. Schömburg ◽  
L. Jennings ◽  
A. A. Cole ◽  
...  
Keyword(s):  
Matrix Metalloproteinase ◽  
Articular Chondrocytes ◽  
Degradation Products ◽  
Collagen Degradation ◽  
Collagen Degradation Products

Structural Studies of Fibrinolysis by Electron and Light Microscopy

1999 ◽  
Vol 82 (08) ◽  
pp. 277-282 ◽  
Author(s):  
Yuri Veklich ◽  
Jean-Philippe Collet ◽  
Charles Francis ◽  
John W. Weisel
Keyword(s):  
Electron Microscopy ◽  
Light Microscopy ◽  
Plasminogen Activator ◽  
Structural Changes ◽  
Molecular Mechanisms ◽  
Degradation Products ◽  
Molecular Model ◽  
Three Dimensional ◽  
Tissue Type ◽  
Type Plasminogen Activator

IntroductionMuch is known about the fibrinolytic system that converts fibrin-bound plasminogen to the active protease, plasmin, using plasminogen activators, such as tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator. Plasmin then cleaves fibrin at specific sites and generates soluble fragments, many of which have been characterized, providing the basis for a molecular model of the polypeptide chain degradation.1-3 Soluble degradation products of fibrin have also been characterized by transmission electron microscopy, yielding a model for their structure.4 Moreover, high resolution, three-dimensional structures of certain fibrinogen fragments has provided a wealth of information that may be useful in understanding how various proteins bind to fibrin and the overall process of fibrinolysis (Doolittle, this volume).5,6 Both the rate of fibrinolysis and the structures of soluble derivatives are determined in part by the fibrin network structure itself. Furthermore, the activation of plasminogen by t-PA is accelerated by the conversion of fibrinogen to fibrin, and this reaction is also affected by the structure of the fibrin. For example, clots made of thin fibers have a decreased rate of conversion of plasminogen to plasmin by t-PA, and they generally are lysed more slowly than clots composed of thick fibers.7-9 Under other conditions, however, clots made of thin fibers may be lysed more rapidly.10 In addition, fibrin clots composed of abnormally thin fibers formed from certain dysfibrinogens display decreased plasminogen binding and a lower rate of fibrinolysis.11-13 Therefore, our increasing knowledge of various dysfibrinogenemias will aid our understanding of mechanisms of fibrinolysis (Matsuda, this volume).14,15 To account for these diverse observations and more fully understand the molecular basis of fibrinolysis, more knowledge of the physical changes in the fibrin matrix that precede solubilization is required. In this report, we summarize recent experiments utilizing transmission and scanning electron microscopy and confocal light microscopy to provide information about the structural changes occurring in polymerized fibrin during fibrinolysis. Many of the results of these experiments were unexpected and suggest some aspects of potential molecular mechanisms of fibrinolysis, which will also be described here.

Fibrinogen Bastia (γ 318 Asp → Tyr) a Novel Abnormal Fibrinogen Characterized by Defective Fibrin Polymerization

1999 ◽  
Vol 82 (12) ◽  
pp. 1639-1643 ◽  
Author(s):  
Karim Chabane Lounes ◽  
Claudine Soria ◽  
Antoine Valognes ◽  
Marie France Turchini ◽  
Jaap Koopman ◽  
...  
Keyword(s):  
Calcium Ions ◽  
Clinical Symptoms ◽  
Degradation Products ◽  
Base Substitution ◽  
Chain Gene ◽  
Fibrinogen Concentration ◽  
Clotting Time ◽  
Terminal Part ◽  
Fibrin Polymerization ◽  
Chain Sequence

SummaryA new congenital dysfibrinogen, Fibrinogen Bastia, was discovered in a 20-year-old woman with no clinical symptoms. The plasma thrombin-clotting time was severely prolonged. The functional plasma fibrinogen concentration was low (0.2 mg/ml), whereas the immunological concentration was normal (2.9 mg/ml). Purified fibrinogen Bastia displayed a markedly prolonged thrombin-clotting time related to a delayed thrombin-induced fibrin polymerization. Both the thrombin-clotting time and the fibrin polymerization were partially corrected by the addition of calcium ions. The anomaly of fibrinogen Bastia was found to be located in the γ-chain since by SDS-PAGE performed according to the method of Laemmli two γ-chains were detected, one normal and one with an apparently lower molecular weight. Furthermore, analysis of plasmin degradation products demonstrated that calcium ions only partially protect fibrinogen Bastia γ-chain against plasmin digestion, suggesting that the anomaly is located in the C-terminal part of the γ-chain. Sequence analysis of PCR-amplified genomic DNA fragments of the propositus demonstrated a single base substitution (G → T) in the exon VIII of the γ chain gene, resulting in the amino acid substitution 318 Asp (GAC) → Tyr (TAC). The PCR clones were recloned and 50% of them contained the mutation, indicating that the patient was heterozygous. These data indicate that residue Asp 318 is important for normal fibrin polymerization and the protective effect of calcium ions against plasmin degradation of the C-terminal part of the γ-chain.

A Monoclonal Antibody-Based Enzyme Immunoassay for Fibrin Degradation Products in Plasma

1988 ◽  
Vol 59 (02) ◽  
pp. 310-315 ◽  
Author(s):  
P W Koppert ◽  
E Hoegee-de Nobel ◽  
W Nieuwenhuizen
Keyword(s):  
Enzyme Immunoassay ◽  
Degradation Products ◽  
Blood Clot ◽  
Tissue Type ◽  
Fibrin Degradation Products ◽  
Type Plasminogen Activator ◽  
Strong Positive Reaction ◽  
Sandwich Type ◽  
Capture Antibody

SummaryWe have developed a sandwich-type enzyme immunoassay (EIA) for the quantitation of fibrin degradation products (FbDP) in plasma with a time-to-result of only 45 minutes.* The assay is based on the combination of the specificities of two monoclonal antibodies (FDP-14 and DD-13), developed in our institute. FDP-14, the capture antibody, binds both fibrinogen degradation products (FbgDP) and FbDP, but does not react with the parent fibrin(ogen) molecules. It has its epitope in the E-domain of the fibrinogen molecule on the Bβ-chain between amino acids 54-118. Antibody DD-13 was raised using D-dimer as antigen and is used as a tagging antibody, conjugated with horse-radish peroxidase. A strong positive reaction is obtained with a whole blood clot lysate (lysis induced by tissue-type plasminogen activator) which is used as a standard. The EIA does virtually not detect FbgDP i. e. purified fragments X, Y, or FbgDP generated in vitro in plasma by streptokinase treatment. This indicates that the assay is specific for fibrin degradation products.We have successfully applied this assay to the plasma of patients with a variety of diseased states. In combination with the assay previously developed by us for FbgDP and for the total amount of FbgDP + FbDP (TDP) in plasma, we are now able to study the composition of TDP in patients plasma in terms of FbgDP and FbDP.

Sign in / Sign up

Export Citation Format

Share Document